MBOT - Microbot Medical secures third U.S. patent for Liberty Robotic System

Microbot Medical (NASDAQ:MBOT) announces that the USPTO has issued a Notice of Allowance for a third patent application covering the Company’s LIBERTY Robotic System. Shares up 8.7% premarket at $5.50. The allowed claims provide protection for embodiments of LIBERTY as a compact robotic device for driving movement of two or more elongate surgical tools, the device having motors and tool actuation assemblies encased within the same device housing. Globally, MBOT now has 47 patents issued/allowed and 26 pending patent applications and is continuously submitting applications to protect its Intellectual Property. Earlier this year, Microbot Medical (MBOT) secured patents for LIBERTY Robotic System in U.S. in November and October 2021.

For further details see:

Microbot Medical secures third U.S. patent for Liberty Robotic System